loadpatents
Patent applications and USPTO patent grants for Koong; Albert C..The latest application filed is for "ire1alpha endonuclease specific inhibitor with cytotoxic activity".
Patent | Date |
---|---|
Ire1alpha endonuclease specific inhibitor with cytotoxic activity Grant 8,993,617 - Koong , et al. March 31, 2 | 2015-03-31 |
Ire1alpha Endonuclease Specific Inhibitor With Cytotoxic Activity App 20130303599 - Koong; Albert C. ;   et al. | 2013-11-14 |
Inhibitors Of The Unfolded Protein Response And Methods For Their Use App 20130150399 - Koong; Albert C. ;   et al. | 2013-06-13 |
Inhibitors of the unfolded protein response and methods for their use Grant 8,372,861 - Koong , et al. February 12, 2 | 2013-02-12 |
Methods Of Monitoring Endoplasmic Reticulum (er) Stress Response App 20120202751 - Koong; Albert C. ;   et al. | 2012-08-09 |
Inhibitors Of The Unfolded Protein Response And Methods For Their Use App 20090312362 - Koong; Albert C. ;   et al. | 2009-12-17 |
Methods To Identify Inhibitors Of The Unfolded Protein Response App 20090291857 - Koong; Albert C. ;   et al. | 2009-11-26 |
Tumor treatment method Grant 5,646,185 - Giaccia , et al. July 8, 1 | 1997-07-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.